James V Cassella - Net Worth and Insider Trading

James V Cassella Net Worth

The estimated net worth of James V Cassella is at least $1 Million dollars as of 2024-04-25. James V Cassella is the Chief Development Officer of Concert Pharmaceuticals Inc and owns about 176,823 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $1 Million. Details can be seen in James V Cassella's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James V Cassella has not made any transactions after 2023-01-30 and currently still holds the listed stock(s).

Transaction Summary of James V Cassella

To

James V Cassella Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James V Cassella owns 3 companies in total, including Concert Pharmaceuticals Inc (CNCE) , Trevi Therapeutics Inc (TRVI) , and Alexza Pharmaceuticals Inc (ALXA) .

Click here to see the complete history of James V Cassella’s form 4 insider trades.

Insider Ownership Summary of James V Cassella

Ticker Comapny Transaction Date Type of Owner
CNCE Concert Pharmaceuticals Inc 2023-01-30 Chief Development Officer
TRVI Trevi Therapeutics Inc 2020-02-13 director
ALXA Alexza Pharmaceuticals Inc 2015-01-23 director & Former EVP & R&D and CSO

James V Cassella Latest Holdings Summary

James V Cassella currently owns a total of 1 stock. James V Cassella owns 176,823 shares of Concert Pharmaceuticals Inc (CNCE) as of January 30, 2023, with a value of $1 Million.

Latest Holdings of James V Cassella

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNCE Concert Pharmaceuticals Inc 2023-01-30 176,823 8.37 1,480,009

Holding Weightings of James V Cassella


James V Cassella Form 4 Trading Tracker

According to the SEC Form 4 filings, James V Cassella has made a total of 6 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 10,106 shares on January 30, 2023, which brought James V Cassella around $84,385.

Insider Trading History of James V Cassella

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James V Cassella Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James V Cassella Ownership Network

Ownership Network List of James V Cassella

No Data

Ownership Network Relation of James V Cassella


James V Cassella Owned Company Details

What does Concert Pharmaceuticals Inc do?

Who are the key executives at Concert Pharmaceuticals Inc?

James V Cassella is the Chief Development Officer of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include CFO & PFO Marc A. Becker , Chief Operating Officer Nancy Stuart , and Chief Legal Officer Jeffrey A Munsie .

Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary

Over the past 18 months, James V Cassella made 2 insider transaction in Concert Pharmaceuticals Inc (CNCE) with a net sale of 12,999. Other recent insider transactions involving Concert Pharmaceuticals Inc (CNCE) include a net sale of 16,093 shares made by Nancy Stuart , a net sale of 11,386 shares made by Jeffrey A Munsie , and a net sale of 11,386 shares made by Marc A. Becker .

In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,104 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,104 shares.

Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Concert Pharmaceuticals Inc Insider Transactions

No Available Data

James V Cassella Mailing Address

Above is the net worth, insider trading, and ownership report for James V Cassella. You might contact James V Cassella via mailing address: 2091 Stierlin Court, Mountain View Ca 94043.

Discussions on James V Cassella

No discussions yet.